The interleukin 17 system in cortical lesions in focal cortical dysplasias

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 2, 2013, Pages 152-163

  He, Jiao Jiang ^a   Li, Song ^a   Shu, Hai Feng ^a   Yu, Si Xun ^a   Liu, Shi Yong ^a   Yin, Qing ^a   Yang, Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Epilepsy; Focal cortical dysplasias; Inflammatory cytokine; Interleukin 17.

Indexed keywords

BETA ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; TRANSCRIPTION FACTOR RELA;

ADOLESCENT; ARTICLE; ASTROCYTE; BRAIN CORTEX LESION; CD4+ T LYMPHOCYTE; CELL COUNT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICAL DYSPLASIA; ENDOTHELIUM CELL; EPILEPTOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; INTRACTABLE EPILEPSY; MALE; MOLECULARLY TARGETED THERAPY; NERVE CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SEIZURE; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; CELL COUNT; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; INTERLEUKIN-17; LONGITUDINAL STUDIES; MALFORMATIONS OF CORTICAL DEVELOPMENT; NEUROFILAMENT PROTEINS; NF-KAPPA B; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; YOUNG ADULT;

EID: 84872833395     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318281262e     Document Type: Article

References (45)

1. Blümcke I, Vinters HV, Armstrong D, et al. Malformations of cortical development and epilepsies: Neuropathological findings with emphasis on focal cortical dysplasia. Epileptic Disord 2009;11:181-93
2. Sisodiya SM, Fauser S, Cross JH, et al. Focal cortical dysplasia type II: Biological features and clinical perspectives. Lancet Neurol 2009;8: 830-43
3. Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158-74
4. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: Neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002;125:1719-32
5. Tassi L, Garbelli R, Colombo N, et al. Type I focal cortical dysplasia: Surgical outcome is related to histopathology. Epileptic Disord 2010;12: 181-91
6. Aronica E, Crino PB. Inflammation in epilepsy: Clinical observations. Epilepsia 2011;52:26-32
7. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803
8. Vezzani A, French J, Bartfai T, et al. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7:31-40
9. Xu S, Cao X. Interleukin-17 and its expanding biological functions. Cell Mol Immunol 2010;7:164-74
10. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21:467-76
11. Wang DD, Zhao YF, Wang GY, et al. IL-17 potentiates neuronal injury induced by oxygen-glucose deprivation and affects neuronal IL-17 receptor expression. J Neuroimmunol 2009;212:17-25
12. Iyer A, Zurolo E, Spliet WG, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 2010; 51:1763-73
13. Zurolo E, Iyer A, Maroso M, et al. Activation of Toll-like receptor, RAGE and HMGB1 signaling in malformations of cortical development. Brain 2011;134:1015-32
14. Schick V, Majores M, Engels G, et al. Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells. Brain Pathol 2007;17:165-73
15. Vezzani A, Granata T. Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia 2005;46:1724-43
16. Rodgers JM, Zhou L, Miller SD. Act1, scene brain: Astrocytes play a lead role. Immunity 2010;32:302-4
17. Jovanovic DV, Di Battista JA, Martel-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160:3513-21
18. Kawanokuchi J, Shimizu K, Nitta A, et al. Production and functions of IL-17 in microglia. J Neuroimmunol 2008;194:54-61
19. Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures. J Neurosci 1999;19:5054-65
20. Li G, Bauer S, Nowak M, et al. Cytokines and epilepsy. Seizure 2011;20: 249-56
21. Campbell IL, Abraham CR, Masliah E, et al Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993;90:10061-65
22. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006;24:128-43
23. Shu HF, Zhang CQ, Yin Q, et al. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol 2010;69:838-49
24. Tzartos JS, Friese MA, Craner MJ, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008;172:146-55
25. Poser CM, Brinar VV. Epilepsy and multiple sclerosis. Epilepsy Behav 2003;4:6-12
26. Calabrese M, De Stefano N, Atzori M, et al. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 2008; 255:581-86
27. De Reuck JL. Stroke-related seizures and epilepsy. Neurol Neurochir Pol 2007;41:144-49
28. Li GZ, Zhong D, Yang LM, et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 2005;62:481-86
29. Andre VM, Wu N, Yamazaki I, et al. Cytomegalic interneurons: A new abnormal cell type in severe pediatric cortical dysplasia. J Neuropathol Exp Neurol 2007;66:491-504
30. Cepeda C, Andre VM, Levine MS, et al. Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis. Epilepsy Behav 2006;9:219-35
31. Aronica E, Leenstra S, Jansen GH, et al. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: Colocalization with N-methyl-d-aspartic acid receptor. Acta Neuropathol (Berl) 2001; 101:383-92
32. Aronica E, Ozbas-Gerceker F, Redeker S, et al. Expression and cellular distribution of high-and low-affinity neurotrophin receptors in malformations of cortical development. Acta Neuropathol (Berl) 2004;108:422-34
33. Wang L, Yi T, Zhang W, et al. IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res 2010;70:10112-20
34. Aronica E, Ravizza T, Zurolo E, et al. Astrocyte immune responses in epilepsy. Glia 2012;60:1258-68
35. Trajkovic V, Stosic-Grujicic S, Samardzic T, et al. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J Neuroimmunol 2001;119:183-91
36. Casamenti F, Prosperi C, Scali C, et al. Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: Implications for Alzheimer's disease. Neuroscience 1999;91:831-42
37. Hewett SJ, Csernansky CA, Choi DW. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 1994;13:487-94
38. Ma X, Reynolds SL, Baker BJ, et al. IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol 2010;184:4898-906
39. Murphy AC, Lalor SJ, LynchMA, et al. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 2010;24:641-51
40. Oh HS, Lee MC, Kim HS, et al. Pathophysiologic characteristics of balloon cells in cortical dysplasia. Childs Nerv Syst 2008;24:175-83
41. Cepeda C, Andre VM, Vinters HV, et al. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia 2005;46:82-88
42. Chamberlain WA, Prayson RA. Focal cortical dysplasia type II (malformations of cortical development) aberrantly expresses apoptotic proteins. Appl Immunohistochem Mol Morphol 2008;16:471-76
43. Oby E, Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006; 47:1761-74
44. Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13:1173-75
45. Qian Y, Liu C, Hartupee J, et al. The adaptor ACT1 is required for interleukin 17Ydependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007;8:247-56